This 88-hour on-demand conference includes 64 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.

In this episode of ASAM Practice Pearls, Dr. Elizabeth Salisbury-Afshar is joined by Drs. Sara Polley and Daniel Kaufman to explore highlights from their Annual Conference session, Artificial Intelligence and the Future of Addiction Medicine. Together, they discuss how artificial intelligence is reshaping addiction medicine, including the many ways AI is already being used in clinical care. The conversation focuses on informed consent, maintaining clinical judgment, and ethical considerations.

This 60-minute on-demand session from the ASAM 57th Annual Conference addresses building community advisory boards in addiction treatment, covering development strategies, ethical considerations, and patient partnership engagement.

This 75-minute on-demand session from the ASAM 57th Annual Conference addresses medication call backs in MOUD programs, balancing diversion control strategies with patient-centered and equitable treatment access approaches.

This 75-minute on-demand session from the ASAM 57th Annual Conference addresses clinical and ethical challenges for patients with addiction and cancer, exploring pain management and care decisions in complex scenarios.

This 75-minute on-demand session from the ASAM 57th Annual Conference addresses legal issues in addiction medicine practice, including medico-legal requirements, risk management, and impacts on professionals and patients.

This 75-minute on-demand session from the ASAM 57th Annual Conference addresses artificial intelligence in addiction medicine, exploring clinical applications, ethical considerations, and risks of AI-related addictive behaviors.

In this episode of ASAM Practice Pearls, Drs. Stephen Taylor and Sharon Stancliff explore social determinants of health (SDoH). They discuss the biopsychosocial model of addiction, emphasizing the importance of understanding social factors such as housing, transportation, and economic stability in providing effective care. They highlight the need for clinicians to engage with patients in their environments, advocate for policy changes, and address racial disparities in addiction treatment, offering practical strategies for clinicians to support patients facing social challenges.

In the Season 2 premiere of ASAM Practice Pearls, Drs. Stephen Taylor and Jeanmarie Perrone follow up on Season 1’s episode, Emerging Illicit Substances: What Clinicians Need to Know. Together, they discuss how medetomidine has continued to spread to different regions and what has changed over the past year. They explore strategies for managing medetomidine withdrawal, keeping patients safe, and preparing for this growing public health threat.

This 75-hour on-demand conference includes 64 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.